Identification and characterization of a pyridoxal 5'-phosphate phosphatase in tobacco plants.

Plant Sci

School of Tea and Food Science & Technology, Anhui Agricultural University, Hefei 230036, People's Republic of China. Electronic address:

Published: January 2019


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Pyridoxal 5'-phosphate (PLP), the catalytically active form of vitamin B, is an important cofactor for many biochemical transformations. PLP is also a very reactive molecule, and the most well-established mechanism for maintaining low levels of free PLP is its dephosphorylation by phosphatases. In our previous study, the crude enzyme extract from tobacco leaves rapidly hydrolyzed PLP at a pH optimum of 5.5. Using PLP as a substrate, a novel acid phosphatase was purified from tobacco leaves and characterized. Whether there is a PLP specific phosphatase in plants is still unknown. In this study, a cDNA clone sharing 34.72% homology with human PLP phosphatase sequences was identified from N. tabacum and characterized. The cDNA encodes a polypeptide of 319 amino acid residues, and the recombinant enzyme purified from E. coli exhibited maximum catalytic activity for PLP at pH 7.5. The properties of the purified enzyme, including pH optimum, metal requirement, optimum substrate and inhibitors were similar to those of human PLP phosphatase. Subcellular localization analysis showed that the PLP phosphatase is mainly located in chloroplast. We down-regulated the gene expression with plant RNA interference technology and found that the down-regulation has a greater impact on the transcription of genes encoding vitamin B metabolic enzymes. Our study further suggested that the PLP phosphatase plays an important role for maintaining PLP homeostasis within the chloroplast in plants.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.plantsci.2018.10.014DOI Listing

Publication Analysis

Top Keywords

plp phosphatase
16
plp
12
pyridoxal 5'-phosphate
8
tobacco leaves
8
human plp
8
phosphatase
7
identification characterization
4
characterization pyridoxal
4
5'-phosphate phosphatase
4
phosphatase tobacco
4

Similar Publications

Persistent low serum alkaline phosphatase (ALP) levels are crucial in identifying genetic disorders such as hypophosphatasia (HPP). This study investigates the causes of low ALP levels in children, aiming to evaluate the demographic and clinical characteristics of those diagnosed with HPP.We evaluated 2243 children and adolescents, ranging from 0 to 19 years old between September 2019 and July 2024, who exhibited at least two ALP levels below the age- and gender-specific lower limit.

View Article and Find Full Text PDF

Mutations Elevate an Underground Pathway to a Physiologically Relevant Protopathway.

Mol Biol Evol

July 2025

Cooperative Institute for Research in Environmental Sciences, University of Colorado, Boulder, CO 80205, USA.

Underground metabolic pathways-leaks in the metabolic network caused by promiscuous enzyme activities and nonenzymatic transformations-can provide the starting point for emergence of novel protopathways if a mutation or environmental change increases flux to a physiologically significant level. This early stage in pathway evolution, in which promiscuous enzymes are still serving their native functions and proper regulation has not yet emerged, is typically hidden from our view. We previously used laboratory evolution to evolve a novel four-step protopathway in ΔpdxB E.

View Article and Find Full Text PDF

This study assessed whether asfotase alfa treatment in Akp2 mice (a model of hypophosphatasia) reversibly normalizes GABA and cystathionine in brain tissue to concentrations in wild-type mice. To do this, metabolite concentrations were analyzed at postnatal days 10 and 48. The data showed that asfotase alfa treatment significantly increased GABA concentrations and significantly decreased cystathionine concentrations in Akp2 mice compared with vehicle-treated Akp2 mice (GABA: 1.

View Article and Find Full Text PDF

Hypophosphatasia and neuropathic pain: related to vitamin B6 metabolism?

JBMR Plus

August 2025

Erasmus MC Bone Center, Department of Internal Medicine, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.

Hypophosphatasia (HPP) is caused by pathogenic variant(s) of the gene encoding tissue-nonspecific alkaline phosphatase (TNSALP). Diminished enzyme activity results in elevated serum concentrations of pyridoxal 5'-phosphate (PLP), the main circulating form of vitamin B6. Neuropathy has been associated with HPP, but the prevalence, pathogenesis, and symptoms remain inadequately understood.

View Article and Find Full Text PDF

Unlabelled: Low serum alkaline phosphatase is the biochemical hallmark of hypophosphatasia. However, it is a non-specific finding. Here we show that a 2-day vitamin B6 challenge is useful to identify carriers of ALPL gene mutations among patients with low serum alkaline phosphatase, with specificity and sensitivity over 90%.

View Article and Find Full Text PDF